ODOMZO Patient Access Program
The ODOMZO Patient Access Program streamlines access to ODOMZO® (sonidegib) for you and your doctor. The program application is used to verify your health insurance benefits and out-of-pocket costs for ODOMZO. Your doctor will fill out and fax the application to the ODOMZO Patient Access Program to start the process.
Commercially insured patients may be eligible for the ODOMZO Co-pay Card Program. Click here to read more.
Publicly insured and uninsured patients may be eligible for a referral to nonprofit foundations for assistance.
Once your doctor submits your application, a program coordinator will then evaluate if you are eligible for financial assistance. (Qualified patients must meet certain medical and financial criteria.)
For more information or any questions, call the ODOMZO Patient Access Program anytime from Monday-Friday, 8 AM - 8 PM EST.
Phone: 1-844-5-ODOMZO (1-844-563-6696)
Start saving on ODOMZO
Co-pay assistance for commercially insured patients
- To activate this card, call 1-877-ODOMZO-1 (1-877-636-6961)(1-877-636-6961) or visit www.activatethecard.com/7436
- Present card to pharmacy
- Maximum benefit of up to $15,000 per calendar year on your ODOMZO prescription. Limitations apply. See full terms and conditions below. This offer is not valid under Medicare, Medicaid, or any other federal or state program. We reserve the right to rescind, revoke, or amend this program without notice
Terms and Conditions
To participate in the ODOMZO® (sonidegib) Co-Pay Program ("Program"), you must present this card, along with a valid prescription for ODOMZO®, to your pharmacist. Patients with commercial health insurance who qualify to participate can pay as little as $10 per month, with a maximum annual benefit of $15,000 per calendar year. Enrollment is subject to the Eligibility Rules and Terms and Conditions, stated below. If you have any questions regarding Eligibility, the Terms and Conditions, or to discontinue participation, please call 1-877-ODOMZO-1 (1-877-636-6961) (8:00 AM-8:00 PM EST, Monday-Friday).
Eligibility Rules: To participate in this Program, you must have commercial health insurance and be a resident of the United States, Puerto Rico, Guam, or the Virgin Islands. The following patients are ineligible for this Program: Patients covered under Medicaid (including Medicaid patients enrolled in a Medicaid Managed Care Plan or a qualified health plan purchased through a health insurance exchange marketplace established by a state government or the federal government); Patients covered by Medicare, a Medicare Part D or Medicare Advantage plan (regardless of whether a specific prescription is covered); Patients covered by TRICARE, CHAMPUS, Puerto Rico Government Health Insurance Plan or any other state or federal medical or pharmaceutical benefit program or pharmaceutical assistance program; Patients with no insurance.
Terms and Conditions You agree not to seek any reimbursement for all or any part of the co-pay assistance received through the Program. By using this card, you are certifying that you understand the Eligibility Rules and Terms and Conditions, that you have responded truthfully to questions when activating the card, and that you will disclose and report your receipt of any Program benefits to your insurer, health plan, or any third party that pays or reimburses you for the cost of medications, if required. This offer may be rescinded, revoked or cancelled at any time without further notice and the rules may be amended at any time without further notice. Disclosures: This Program is not insurance. The Program is void where prohibited by law, taxed, or restricted. Any benefit provided is not transferable and cannot be combined with any other program, free trial, discount, prescription savings card, or other offer. No purchase other than for an ODOMZO® prescription, is required to participate. Personal data that you provide to the Program may be collected, analyzed, and shared with the program sponsor for market research and other lawful purposes but only in aggregated and de-identified form.